GLP-1 use linked to improved survival in patients with cancer

Darovasertib plus crizotinib improves outcomes in HLA-A2–negative metastatic uveal melanoma

Early-onset gastrointestinal cancers show more advanced disease and wider racial survival gaps

Xaluritamig plus abiraterone shows promising anti-tumour activity with manageable safety in chemotherapy-naïve mCRPC

Tarlatamab improves brain metastases control and survival compared to chemo in SCLC

Mezigdomide plus carfilzomib and dexamethasone delays disease progression in R/R multiple myeloma

Mobile app-based symptom monitoring helps maintain quality of life in advanced cancer

Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancer

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Lorlatinib delivers 7-year progression-free survival and durable brain control in ALK+ NSCLC

Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancer

Abemaciclib shows benefit in dedifferentiated liposarcoma